{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T23:10:02Z","timestamp":1749165002928,"version":"3.41.0"},"reference-count":66,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Kryptosporidien bzw. die von ihnen ausgel\u00f6ste Kryptosporidiose geh\u00f6rt zu den relevantesten Infektionen des Darmtraktes. Die einzelligen Parasiten infizieren die Darmzellen und l\u00f6sen Kr\u00e4mpfe, Gewichtsverlust und Durchfall aus. Eine besondere Rolle nehmen Kryptosporidien bei AIDS-Patienten ein. Hier werden sie zu jenen Krankheiten gez\u00e4hlt, die AIDS-definierend sind. Aufgrund dieser Relevanz ist die Suche nach Impfstoffen ein relevantes Ziel der gastroenterologischen Forschung. Doch wie realistisch sind solche Impfstoffe? Dieser Artikel beschreibt die Krankheit Kryptosporidiose und gibt einen \u00dcberblick \u00fcber die aktuellen Therapeutika wie auch die m\u00f6glichen Impfstoffkandidaten.<\/jats:p>","DOI":"10.1055\/a-2551-1670","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:11:41Z","timestamp":1745968301000},"page":"596-603","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutika und (hypothetische) Impfungen gegen humane Kryptosporidien"],"prefix":"10.1055","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-6985","authenticated-orcid":false,"given":"Yannick","family":"Borkens","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charite Medical Faculty Berlin, Berlin, Germany"},{"name":"Humboldt University of Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1556\/1886.2019.00019","article-title":"Cryptosporidium Infection: Epidemiology, Pathogenesis, and Differential Diagnosis","volume":"9","author":"E Gerace","year":"2019","journal-title":"Eur J Microbiol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1051\/parasite\/2020011","article-title":"Update on Cryptosporidium spp.: highlights from the Seventh International Giardia and Cryptosporidium Conference","volume":"27","author":"G Widmer","year":"2020","journal-title":"Parasite"},{"issue":"01","key":"ref3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/2229-5070.202290","article-title":"Revisiting the global problem of cryptosporidiosis and recommendations","volume":"7","author":"AK Shrivastava","year":"2017","journal-title":"Trop Parasitol"},{"issue":"12","key":"ref4","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.3390\/ijerph15122730","article-title":"Exotic Tourist Destinations and Transmission of Infections by Swimming Pools and Hot Springs\u2013A Literature Review","volume":"15","author":"A Mavridou","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"04","key":"ref5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1128\/AEM.01422-10","article-title":"Detection and characterization of a Cryptosporidium isolate from a southern elephant seal (Microunga leonina) from the Antarctic peninsula","volume":"77","author":"C Rengifo-Herrera","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"04","key":"ref6","first-page":"1007","article-title":"Parasites in soil samples from Signy Island, Antarctica","volume":"35","author":"PKC Lim","year":"2018","journal-title":"Trop Biomed"},{"issue":"01","key":"ref7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.exppara.2009.07.014","article-title":"Biology of cryptosporidium from marsupial hosts","volume":"124","author":"ML Power","year":"2010","journal-title":"Exp Parasitol"},{"issue":"12","key":"ref9","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/s41564-019-0539-x","article-title":"Life cycle progression and sexual development of the apicomplexan parasite cryptosporidium parvum","volume":"4","author":"J Tandel","year":"2019","journal-title":"Nat Microbiol"},{"issue":"22","key":"ref10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMra013170","article-title":"Cryptosporidiosis","volume":"346","author":"XM Chen","year":"2002","journal-title":"N Engl J Med"},{"issue":"01","key":"ref11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.exppara.2009.02.003","article-title":"Minireview: clinical cryptosporidiosis","volume":"124","author":"RM Chalmers","year":"2010","journal-title":"Exp Parasitol"},{"issue":"03","key":"ref12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2019.18691","article-title":"Cryptosporidiosis","volume":"323","author":"AN Desai","year":"2020","journal-title":"JAMA"},{"issue":"05","key":"ref13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pt.2019.11.003","article-title":"Cryptosporidium parvum","volume":"36","author":"JE Dumaine","year":"2020","journal-title":"Trends Parasitol"},{"issue":"04","key":"ref14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1473-3099(01)00121-9","article-title":"Cryptosporidiosis: an update","volume":"1","author":"M Kosek","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1017\/S0950268809002696","article-title":"Cryptosporidiosis from a community swimming pool: outbreak investigation and follow-up study","volume":"137","author":"TK Boehmer","year":"2009","journal-title":"Epidemiol Infect"},{"key":"ref16","first-page":"D6901","article-title":"Cryptosporidiose bij een dreumes","volume":"167","author":"K van der Laan","year":"2023","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"10","key":"ref17","first-page":"627","article-title":"Criptosporidiosis respiratoria","volume":"14","author":"MC Turrientes","year":"1996","journal-title":"Entferm Infecc Microbiol Clin"},{"issue":"03","key":"ref18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/CMR.00115-13","article-title":"The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation","volume":"27","author":"JK Sponseller","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"05","key":"ref19","first-page":"519","article-title":"Respiratory cryptosporidiosis in a patient with malignant lymphoma. Report of a case and review of the literature","volume":"114","author":"WD Travis","year":"1990","journal-title":"Arch Pathol Lab Med"},{"issue":"04","key":"ref20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/BF01743372","article-title":"Pulmonary cryptosporidiosis in the acquired immunodeficiency syndrome","volume":"24","author":"JL Meynard","year":"1996","journal-title":"Infection"},{"issue":"03","key":"ref21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0255-0857.53199","article-title":"AIDS-associated parasitic diarrhoea","volume":"27","author":"DR Arora","year":"2009","journal-title":"Indian J Med Microbiol"},{"issue":"04","key":"ref22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.24884\/0042-4625-2014-173-4-92-94","article-title":"\u041a\u0440\u0438\u043f\u0442\u043e\u0441\u043f\u043e\u0440\u0438\u0434\u0438\u043e\u0437 \u043f\u043e\u0434\u0436\u0435\u043b\u0443\u0434\u043e\u0447\u043d\u043e\u0439 \u0436\u0435\u043b\u0435\u0437\u044b","volume":"173","author":"NA Ma\u012dstrenko","year":"2014","journal-title":"Vestn Khir Im I I Grek"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.actatropica.2018.08.018","article-title":"Widespread occurrence of Cryptosporidium infections in patients with HIV\/AIDS: Epidemiology, clinical feature, diagnosis, and therapy","volume":"187","author":"RJ Wang","year":"2018","journal-title":"Acta Trop"},{"issue":"02","key":"ref24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s15010-024-02188-y","article-title":"AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999\u20132018","volume":"52","author":"A Pantke","year":"2024","journal-title":"Infection"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/gut.43.3.476","article-title":"Gastric involvement in AIDS associated cryptosporidiosis","volume":"43","author":"P Rossi","year":"1998","journal-title":"Gut"},{"issue":"01","key":"ref26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/tp.TP_34_17","article-title":"Laboratory diagnosis of cryptosporidiosis","volume":"8","author":"S Khurana","year":"2018","journal-title":"Trop Parasitol"},{"issue":"01","key":"ref27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21708\/avb.2019.13.1.7977","article-title":"Occurrence of Cryptosporidium spp. and its association with ponderal development and diarrhea episodes in nellore mixed breed cattle","volume":"13","author":"BS Abreu","year":"2019","journal-title":"Acta Vet Bras"},{"issue":"06","key":"ref28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/gut.41.6.801","article-title":"Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travellers","volume":"41","author":"T Jelinek","year":"1997","journal-title":"Gut"},{"issue":"08","key":"ref29","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1017\/S0950258815003131","article-title":"Evolving epidemiology of reported cryptosporidiosis cases in the United States, 1995 \u2013 2012","volume":"144","author":"JE Painter","year":"2016","journal-title":"Epidemiol Infect"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00253-003-1302-y","article-title":"Emerging water-borne pathogens","volume":"61","author":"S Sharma","year":"2003","journal-title":"Appl Microbiol Biotechnol"},{"issue":"05","key":"ref32","doi-asserted-by":"publisher","first-page":"e0004729","DOI":"10.1371\/journal.pntd.0004729","article-title":"The burden of Cryptosporidium diarrheal disease among children < 24 months of age in moderate\/high mortality regions of Sub-Saharan Africa and South Asia, utilizing data from the Global Enteric Multicenter Study (GEMS)","volume":"10","author":"SO Sow","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.watres.2018.10.069","article-title":"Cryptosporidium concentrations in rivers worldwide","volume":"149","author":"LC Vermeulen","year":"2019","journal-title":"Water Res"},{"issue":"10","key":"ref34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3201\/eid2310.152037","article-title":"Economic Assessment of Waterborne Outbreak of Cryptosporidiosis","volume":"23","author":"A Chyzheuskaya","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"07","key":"ref35","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","article-title":"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens","volume":"75","author":"S Hoffmann","year":"2012","journal-title":"J Food Prot"},{"issue":"05","key":"ref36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/fpd.2013.1658","article-title":"Disease-outcome trees, EQ-5D scores, and estimated annual losses of quality-adjusted life years (QALYs) for 14 foodborne pathogens in the United States","volume":"11","author":"M Batz","year":"2014","journal-title":"Foodborne Pathog Dis"},{"issue":"08","key":"ref38","doi-asserted-by":"publisher","first-page":"e0182820","DOI":"10.1371\/journal.pone.0182820","article-title":"Pediatric cryptosporidiosis: An evaluation of health care and societal costs in Peru, Bangladesh and Kenya","volume":"12","author":"ER Rafferty","year":"2017","journal-title":"PLoS One"},{"issue":"01","key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10393-004-0011-z","article-title":"Introduction","volume":"1","author":"BA Wilcox","year":"2004","journal-title":"EcoHealth"},{"issue":"10","key":"ref41","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1086\/320171","article-title":"Paromomycin in cryptosporidiosis","volume":"31","author":"AC White Jr","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref42","first-page":"1161","article-title":"Nitazoxanide","volume":"42","author":"A Parashar","year":"2005","journal-title":"Indian Pediatr"},{"issue":"05","key":"ref43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/QCO.0b013e32833de052","article-title":"Treatment of cryptosporidiosis: do we know what we think we know?","volume":"23","author":"MM Cabada","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"01","key":"ref44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13071-017-2111-y","article-title":"Cryptosporidium and Giardia in Africa: current and future challenges","volume":"10","author":"SA Squire","year":"2017","journal-title":"Parasit Vectors"},{"issue":"03","key":"ref45","doi-asserted-by":"publisher","first-page":"e0009057","DOI":"10.1371\/journal.pntd.0009057","article-title":"Use-case scenarios for an anti-Cryptosporidium therapeutic","volume":"15","author":"PG Ashigbie","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"06","key":"ref46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/pathogens11060653","article-title":"Octaarginine improves the efficacy of Nitazoxanide against Cryptosporidium parvum","volume":"11","author":"T Nguyen-Ho-Bao","year":"2022","journal-title":"Pathogens"},{"issue":"02","key":"ref47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0049475520916978","article-title":"The Mosquirix (RTS.S) malaria vaccine","volume":"50","author":"M Cotton","year":"2020","journal-title":"Trop Doct"},{"issue":"10","key":"ref48","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00108-021-01155-1","article-title":"Toxoplasma gondii \u2013 gegenw\u00e4rtige Arzneimittel und zuk\u00fcnftige Impfstoffe gegen eine untersch\u00e4tzte Protozoonose","volume":"62","author":"Y Borkens","year":"2021","journal-title":"Internist"},{"issue":"06","key":"ref49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40259-023-00623-4","article-title":"Malaria vaccines: progress to date","volume":"37","author":"DI Stanisic","year":"2023","journal-title":"BioDrugs"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biotechadv.2006.08.003","article-title":"Molecular targets for detection and immunotherapy in Cryptosporidium parvum","volume":"25","author":"JI Boulter-Bitzer","year":"2007","journal-title":"Biotechnol Adv"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1128\/IAI.00944-06","article-title":"Proteolytic processing of the Cryptosporidium glycoprotein gp40\/15 by human furin and by a parasite-derived furin-like protease activity","volume":"75","author":"JW Wanyiri","year":"2007","journal-title":"Infect Immun"},{"issue":"06","key":"ref52","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.4161\/hv.28485","article-title":"Prospects for immunotherapy and vaccines against Cryptosporidium","volume":"10","author":"JR Mead","year":"2014","journal-title":"Hum Vaccin Immunther"},{"issue":"06","key":"ref53","doi-asserted-by":"publisher","first-page":"e18910615540","DOI":"10.33448\/rsd-v10i6.15540","article-title":"Vaccine development for cryptosporidiosis: systematic review","volume":"10","author":"DRR da Silva","year":"2021","journal-title":"Res Soc Dev"},{"issue":"S 50","key":"ref54","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1550-7408.2003.tb00622.x","article-title":"IL-12 knockout C57BL\/6 mice are protected from re-infection with Cryptosporidium parvum after challenge","author":"NH Ehigiator","year":"2003","journal-title":"J Eukaryot Microbiol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1645\/0022-3395(2003)089[0639:TEOIOT]2.0.CO;2","article-title":"The effect of gamma-irradiation on the viability of Cryptosporidium parvum","volume":"89","author":"JR Yu","year":"2003","journal-title":"J Parasitol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1645\/GE-3333RN","article-title":"Protection of calves against cryptosporidiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts","volume":"90","author":"M Jenkins","year":"2004","journal-title":"J Parasitol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"102210","DOI":"10.1016\/j.coi.2022.102210","article-title":"Viral vector vaccines","volume":"77","author":"N McCann","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1128\/CVI.00089-09","article-title":"Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice","volume":"16","author":"AJ Benitez","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"06","key":"ref59","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/ph15060756","article-title":"Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production","volume":"15","author":"C Bayart","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1128\/CVI.05197-11","article-title":"Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species","volume":"18","author":"PA Manque","year":"2011","journal-title":"Clin Vaccin Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.vaccine.2012.12.007","article-title":"Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: Impact of malnutrition with preservation of cytokine secretion","volume":"31","author":"JK Roche","year":"2013","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00284-011-9894-4","article-title":"Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice","volume":"62","author":"XR Geriletu","year":"2011","journal-title":"Curr Microbiol"},{"issue":"01","key":"ref64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/bioe.26271","article-title":"Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii","volume":"5","author":"B Douradinha","year":"2013","journal-title":"Bioengineered"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1128\/IAI.67.4.1677-1682","article-title":"Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in rhesus monkeys","volume":"67","author":"M Di Cristina","year":"1999","journal-title":"Infect Immun"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1128\/IAI.71.10.6027-6034.2003","article-title":"Expression of Cpgp40\/15 in Toxoplasma gondii: a surrogate system for the study of Cryptosporidium glycoprotein antigens","volume":"71","author":"RM O\u2019Connor","year":"2003","journal-title":"Infect Immun"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1645\/GE-364R1","article-title":"Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects","volume":"91","author":"H Shirafuji","year":"2005","journal-title":"J Parasitol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/s0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"E Jongert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1086\/503748","article-title":"Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice","volume":"193","author":"M Barrier","year":"2006","journal-title":"J Infect Dis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vaccine.2010.10.034","article-title":"Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection","volume":"29","author":"C Wang","year":"2010","journal-title":"Vaccine"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"902098","DOI":"10.3389\/fpara.2022.902098","article-title":"Frontiers in Parasitology Grand Challenge","volume":"1","author":"A Loukas","year":"2022","journal-title":"Front Parasitol"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2551-1670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T22:44:46Z","timestamp":1749163486000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2551-1670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":66,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2551-1670","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"type":"print","value":"0044-2771"},{"type":"electronic","value":"1439-7803"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}